Korea Pharma
Launch date
Employees
Market cap
€135m
Enterprise valuation
€124m (Public information from Sep 2024)
Share price
KRW16450 032300.KQ
Company register number 1248115899
Seoul South Korea (HQ)
Financials
Estimates*
| KRW | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 71.5b | 79.6b | 81.0b | 83.2b |
| % growth | - | 11 % | 2 % | 3 % |
| EBITDA | 6.8b | 7.4b | 8.6b | 7.5b |
| % EBITDA margin | 10 % | 9 % | 11 % | 9 % |
| Profit | 3.2b | 6.4b | (1.1b) | 83.8m |
| % profit margin | 4 % | 8 % | (1 %) | - |
| EV / revenue | 3.3x | 6.5x | 2.8x | 2.9x |
| EV / EBITDA | 34.8x | 70.5x | 26.3x | 32.8x |
| R&D budget | 6.2b | 4.9b | 2.5b | 2.3b |
| R&D % of revenue | 9 % | 6 % | 3 % | 3 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
